NALOXONE HCI .4 mg/mL
NALOXONE HCI · INJECTION, SOLUTION · HF Acquisition Co. LLC, DBA Health First
NALOXONE HCI is a injection, solution containing naloxone hci at .4 mg/mL, taken intramuscular. Manufactured by HF Acquisition Co. LLC, DBA Health First.
Key Facts
- Brand Name
- NALOXONE HCI
- Generic Name
- NALOXONE HCI
- NDC Code (Product)
51662-1242- Manufacturer
- HF Acquisition Co. LLC, DBA Health First
- Strength
- .4 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA070256
- Marketing Start
- 08/18/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is NALOXONE HCI used for?
NALOXONE HCI contains NALOXONE HCI. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is NALOXONE HCI a controlled substance?
NALOXONE HCI is not classified as a controlled substance by the DEA.
What is the generic name for NALOXONE HCI?
The generic name for NALOXONE HCI is NALOXONE HCI. There are no other listed brand versions of NALOXONE HCI.
What is the NDC code for NALOXONE HCI .4 mg/mL?
The NDC (National Drug Code) for NALOXONE HCI .4 mg/mL is 51662-1242, listed by HF Acquisition Co. LLC, DBA Health First.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)